Search - tctmd.com

Displaying 221 - 240 of 320

Sort: Relevancy | Date

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Presenter: Yuejin Yang

October 29, 2013

Presentation TCT 2013

TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case...

Presenter: Samer Arnous

October 29, 2013

Presentation TCT 2013

From Xience V to Prime to Xpedition: Stent Design Evolution and Clinical Trial Results (SPIRIT and Others)

Presenter: James Hermiller Jr

October 28, 2013

Presentation TCT 2013

Latest Results from ABSORB Extend: Comparison with Xience

Presenter: Bernard Chevalier

October 27, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

October 15, 2013

News Daily News

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

October 15, 2013

Presentation

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

Presenter: F. Liistro

October 14, 2013

Presentation

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

Presenter: Flavio Ribichini

September 23, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

September 20, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

L.A. McKeown

May 03, 2013

Advertisement

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case...

From Xience V to Prime to Xpedition: Stent Design Evolution and Clinical Trial Results (SPIRIT and Others)

Latest Results from ABSORB Extend: Comparison with Xience

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

Contemporary ZES Perform Well in Treating In-Stent Restenosis

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

TWENTE: Still Few Differences between ZES and EES at 2 Years

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content